Results 111 to 120 of about 11,035 (153)

Insights into the interaction of Fibrinogen with Timolol Maleate and elucidation of binding sites via. spectroscopic and molecular docking study. [PDF]

Sci Rep
Rao NG, Pathania AR, Kour HD, Ballal S, Singh A, Bhowmik A, Zeru BA.   +6 more
europepmc   +1 more source

Peptide dendrimer and hyaluronic acid modified nanovesicles for ocular delivery of timolol maleate and siRNA. [PDF]

Sci Rep
Naik S, Jain N, Theruveethi N, Mutalik S.   +3 more
europepmc   +1 more source

In Vivo Comparison of Intracameral and Intravitreal Implantation of a Timolol Maleate Miniaturized Injectable Delivery System Device. [PDF]

Ophthalmol Sci
Ma CJ, Zhang Y, Bernards DA, Bloomer M, Dickson J, Rajadas J, Vyakarnam M, Desai TA, Bhisitkul RB.   +8 more
europepmc   +1 more source

Retraction: Development of Timolol Maleate-Loaded Poloxamer-co-Poly (acrylic acid) based hydrogel for controlled drug delivery. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Timolol Maleate in Situ Ophthalmic Mucoadhesive-Thermosensitive Gel: Development and Characterization. [PDF]

Turk J Pharm Sci
Kral Ö, Turan Ayhan E, Ilbasmıs-Tamer S, Tırnaksız FF.   +3 more
europepmc   +1 more source

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial. [PDF]

J Indian Assoc Pediatr Surg
Singh S, Srivastava NK, Upadhyaya A, Kumar M, Pawar N, Kapoor R.   +5 more
europepmc   +1 more source

Resolution of post-trauma conjunctival inclusion cyst using 0.5% timolol maleate eyedrops. [PDF]

Arq Bras Oftalmol
Antunes-Foschini R, Alves LF.
europepmc   +1 more source

Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas. [PDF]

Pak J Med Sci
Mazhar A, Naureen A, Mallick YA, Samad L.   +3 more
europepmc   +1 more source

Application of Tablet in Tablet technique to design and characterize immediate and modified release tablets of Timolol maleate. [PDF]

Heliyon
Gaikwad SS, Kshirsagar SJ.
europepmc   +1 more source

Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial.

JAMA Ophthalmol, 2020
Kurian A, Reghunadhan I, Thilak P, Soman I, Nair U.   +4 more
europepmc   +1 more source